000739 Stock Overview
Provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Apeloa Pharmaceutical Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥15.17 |
| 52 Week High | CN¥19.70 |
| 52 Week Low | CN¥10.66 |
| Beta | 0.0028 |
| 11 Month Change | 0.40% |
| 3 Month Change | 3.83% |
| 1 Year Change | -8.17% |
| 33 Year Change | -54.74% |
| 5 Year Change | 24.96% |
| Change since IPO | 826.03% |
Recent News & Updates
Lacklustre Performance Is Driving Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Low P/E
Aug 07
Is Apeloa PharmaceuticalLtd (SZSE:000739) Using Too Much Debt?
Jun 24Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
May 08Shareholder Returns
| 000739 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 2.1% | -1.7% | -2.4% |
| 1Y | -8.2% | -10.7% | -20.1% |
Return vs Industry: 000739 matched the CN Pharmaceuticals industry which returned -8.9% over the past year.
Return vs Market: 000739 exceeded the CN Market which returned -19.1% over the past year.
Price Volatility
| 000739 volatility | |
|---|---|
| 000739 Average Weekly Movement | 4.4% |
| Pharmaceuticals Industry Average Movement | 5.1% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in CN Market | 8.7% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 000739 has not had significant price volatility in the past 3 months.
Volatility Over Time: 000739's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 7,208 | Chun He | www.apeloa.com |
Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. The company offers preparation products, including cardio-cerebrovascular, anti-infection, anti-tumor, anti-viral, and special drugs. It offers its products under the Tianliwei, Beshin, Yosemade, Jutai, and other brands.
Apeloa Pharmaceutical Co.,Ltd Fundamentals Summary
| 000739 fundamental statistics | |
|---|---|
| Market cap | CN¥17.58b |
| Earnings (TTM) | CN¥1.08b |
| Revenue (TTM) | CN¥11.95b |
16.3x
P/E Ratio1.5x
P/S RatioIs 000739 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000739 income statement (TTM) | |
|---|---|
| Revenue | CN¥11.95b |
| Cost of Revenue | CN¥9.12b |
| Gross Profit | CN¥2.82b |
| Other Expenses | CN¥1.74b |
| Earnings | CN¥1.08b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.93 |
| Gross Margin | 23.63% |
| Net Profit Margin | 9.03% |
| Debt/Equity Ratio | 15.3% |
How did 000739 perform over the long term?
See historical performance and comparison